CNBX - Cannabics files a PCT patent application for proprietary cancer treatment formulations

Cannabics Pharmaceuticals (CNBX) announces that it has filed a patent application under the Patent Cooperation Treaty ((PCT)) for novel formulations developed for treatment of various cancer types.The patent application includes preclinical supporting data collected from in-vitro experiments performed in the company's in-house drug discovery facilities in Israel, as well as from in-vivo experiments performed on mice, Cannabics said.

For further details see:

Cannabics files a PCT patent application for proprietary cancer treatment formulations